BIOMERICA INC Cash Flow Statement
BMRA|14 years of annual SEC 10-K data (FY2012-FY2025)
Covers operating cash flow, capital expenditures, free cash flow, share buybacks, and dividends paid across 14 fiscal years. All figures from audited SEC 10-K filings.
At a glance
Operating Cash Flow
N/A
FY2025
Free Cash Flow
N/A
FY2025
Capital Expenditures
N/A
Cash used for long-term assets
Dividends Paid
N/A
FY2025
Key Data Points
- Altman Z-Score -6.26 (distress zone, below 1.23 threshold)
- Piotroski F-Score: 1/9 criteria passed
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | - | -$5.0M | -$6.0M | -$7.1M | -$4.5M | -$7.4M | -$2.4M | -$2.4M | -$1.5M | -$908.6K | -$1.5M | -$331.4K | -$215.7K | $537.0K |
| Depreciation & Amortization | - | $87.0K | $81.0K | $84.0K | $339.0K | $105.0K | $101.2K | $101.2K | $111.1K | $144.9K | $156.3K | $178.2K | $177.5K | $187.3K |
| Operating Cash Flow | - | -$3.8M | -$5.4M | -$5.5M | -$479.0K | -$5.3M | -$2.2M | -$2.2M | -$1.2M | -$722.9K | -$208.8K | -$405.5K | -$862.3K | $1.4M |
| Capital Expenditures | - | $51.0K | $51.0K | $64.0K | $57.0K | $135.9K | $101.1K | $101.1K | $130.3K | $96.1K | $91.6K | $10.5K | $137.2K | $257.1K |
| Free Cash Flow | - | -$3.9M | -$5.4M | -$5.5M | -$536.0K | -$5.4M | -$2.3M | -$2.3M | -$1.3M | -$818.9K | -$300.3K | -$416.0K | -$999.5K | $1.1M |
| FCF Margin | - | -73.3% | -99.9% | -103.7% | -2.8% | -74.8% | -45.1% | -45.1% | -23.4% | -14.1% | -5.8% | -8.4% | -19.5% | 17.6% |